drugset / Trial / NCT01073670

Indomethacin and Cardiac Bypass Surgery

NCT01073670

Phase 4 Completed 82 enrolled Queen's University
RandomizedParallel-groupTriple-blindSupportive care

Summary

Following signed informed consent, patients scheduled for elective cardiac surgery were randomly assigned to one of 3 groups to be given acetaminophen, Indomethacin or a combination of both immediately following induction and then at 6, 12, 18 \& 24 hours following surgery. Our primary outcome measure was the amount of blood drained from the mediastinal tubes and chest drains. Secondary outcome measures included conventional blood coagulation indices as well as other measures of clotting as indicated by thromboelastography (TEG). Other secondary outcome measures included consumption of morphine equivalents and pain scores.

Timeline

Start
2000-08
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 650 mg Other
Comparator Acetaminophen Small molecule 1300 mg Other
Subject Indomethacin Small molecule 25 mg Other
Subject Indomethacin Small molecule 50 mg Other

Indications